Pedestrians crossing an avenue in front of historic buildings in Vienna, a territory integrated into the PAC region of the Ferrer group.

Global presence

Ferrer Central Europe

Present in Austria since 2019

A professional from the Ferrer company smiling, looking at the camera and talking through headphones at her workstation in the office.

In 2019, Ferrer strengthened its presence in Central Europe with the opening of its subsidiary in Austria, from where it also coordinates activities in the Czech Republic and Poland. This regional structure allows us to be closer to health systems and people living with serious and highly complex diseases.

In this region, we develop our activity with a clear hospital focus, working to facilitate access to specialized therapeutic solutions and support rigorous, safe and patient-centered clinical practice. All this, in coherence with our purpose of using business activity as a driving force to generate a positive impact on society.

Hospital use and interventional cardiology

Ferrer's activity in Central Europe is mainly carried out in the hospital environment, in clinical contexts that require a high level of specialisation and precision. We work to facilitate access to specialized therapeutic solutions that support healthcare professionals in decision-making in critical situations and high clinical complexity.

Find out more

Pulmonary vascular and interstitial diseases

Ferrer's main focus in Central Europe is the area of rare pulmonary vascular diseases, an area with significant unmet medical needs and a significant impact on the lives of affected people. Our approach combines scientific knowledge, experience in hospital environments and close collaboration with healthcare professionals, with the aim of generating a positive impact on highly complex diseases.

Find out more

Rare neurological diseases

Ferrer is reinforcing its commitment to rare neurological diseases, an area with great unmet medical needs and a significant impact on the lives of affected people and their families. Our approach combines scientific knowledge, collaboration with the medical community and a strong commitment to patients, with the aim of contributing to earlier diagnosis, better clinical management and a better quality of life.

Find out more